Evogene Ltd.
EVGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9,937 | $9,249 | $8,498 | $12,708 |
| - Cash | $5,626 | $8,329 | $7,495 | $15,301 |
| + Debt | $2,520 | $12,685 | $12,963 | $12,874 |
| Enterprise Value | $6,831 | $13,605 | $13,966 | $10,281 |
| Revenue | $312 | $884 | $2,444 | $1,611 |
| % Growth | -64.7% | -63.8% | 51.7% | – |
| Gross Profit | -$126 | $458 | $251 | $263 |
| % Margin | -40.4% | 51.8% | 10.3% | 16.3% |
| EBITDA | -$1,978 | -$2,546 | -$1,944 | $752 |
| % Margin | -634% | -288% | -79.5% | 46.7% |
| Net Income | $3,874 | -$4,462 | -$2,587 | $427 |
| % Margin | 1,241.7% | -504.8% | -105.9% | 26.5% |
| EPS Diluted | 0.44 | -0.62 | -0.38 | 0.063 |
| % Growth | 171% | -63.2% | -705.1% | – |
| Operating Cash Flow | -$3,791 | -$2,301 | -$5,182 | -$5,207 |
| Capital Expenditures | -$11 | -$2 | -$122 | -$322 |
| Free Cash Flow | -$3,802 | -$2,303 | -$5,304 | -$5,529 |